ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

June 18, 1993

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986

NCI says SELECT study is close to full enrollment.

April 23, 2004

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995